v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (23,734) $ (29,621)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 7,834 11,826
Inventory write-down (recovery), net 152 (96)
Depreciation and amortization expense 442 577
Loss on debt extinguishment 107 0
Amortization of debt discount and debt issuance costs 175 24
PIK interest incurred but not paid on term loan 270 0
Net accretion of discounts on marketable securities 0 (339)
Change in fair value of common stock warrant liability (39) 0
Non-cash lease expense 802 615
Net changes in operating assets and liabilities:    
Accounts receivable (297) (1,941)
Inventory (1,207) 1,066
Prepaid expenses and other current assets 492 1,099
Other assets (51) (359)
Accounts payable 773 2,645
Accrued liabilities (379) (2,364)
Income taxes payable (14) 92
Lease liabilities (629) (293)
Deferred tax liability (6) 0
Deferred revenue (2) (61)
Net cash used in operating activities (15,311) (17,130)
Cash flows from investing activities    
Purchases of investments 0 (5,651)
Maturities of investments 0 27,785
Purchases of property and equipment and internal software development costs (10) (350)
Net cash (used in) provided by investing activities (10) 21,784
Cash flows from financing activities    
Repayment of debt (37,000) 0
Proceeds from debt 38,785 0
Repayment of credit agreement (53) (48)
Payment of debt discounts and issuance costs (460) (47)
Proceeds from exercise of common stock options 40 138
Proceeds from issuance of common stock under the employee stock purchase plan 201 554
Net cash provided by financing activities 1,513 597
Effect of exchange rate changes on cash and cash equivalents (99) (688)
Net (decrease) increase in cash, cash equivalents, and restricted cash (13,907) 4,563
Cash, cash equivalents, and restricted cash at beginning of the period 70,009 71,162
Cash, cash equivalents, and restricted cash at end of the period 56,102 75,725
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets:    
Cash and cash equivalents 55,843 75,466
Restricted cash 259 259
Cash, cash equivalents, and restricted cash in consolidated balance sheets 56,102 75,725
Supplemental non-cash items:    
Issuance of common stock warrants 1,383 0
Purchases of property and equipment in accounts payable and accrued liabilities 8 75
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 283 214
Cash paid for interest $ 1,897 $ 1,572